Genome Group Rips Human Cloning Scientists at the Human Genome Organization have condemned plans for human cloning, saying it raises deep concerns over moral issues and arguing that the technology was far from mature and its side effects were unknown.
As Pipelines Wither, Pharma and FDA Explore Whether Microarrays are Ready for Primetime When can the pharmaceutical industry start trusting the technology? When should it make the leap from investigative, experimental technique to industry standard? And should the FDA start using microarray data to make critical decisions about the safety and efficacy of new drugs?
Get new actionable insights and updates from BiotechBlog
